Why choose MoleMax Pro?
MoleMax Systems
A new era of skin imaging is here.
Designed to revolutionise digital dermoscopy, the new MoleMax Pro ticks all the boxes for cost-effective medical diagnosis, more thorough high-resolution detections, improved workflow and better patient satisfaction.
Upgrade your MoleMax skin cancer screening services.
Low-cost opportunity to expand your services
Revolutionise Your Skin Cancer Detection with MoleMax Technology
Molemax Systems
The MoleMax Pro offers a comprehensive imaging and diagnosis systems with 2 cameras for macro, close-up and micro. The software is packed with features including body mapping, live imaging, localisation, follow-up, trending, diagnosis, reporting and practice management software integration.
Software
MoleMax Systems
There are many advantages of using the MoleMax Pro compared to other standard dermatoscopes on the market.
Durability
Ergonomic Design
Magnification
Polarised and Non-Polarised Imaging
Contact and Non-Contact Dermoscopy
High Quality Imaging
Strength through our unique diversity
Seamless digital live imaging MoleMax Pro. Allows for input of patient details. Mole/Lesion measuring ruler provides accurate measurement of any mole/lesion as well as an additional new option to label excision margins. Localisation on dummy body map. PDF report generation and print options with body map location. New feature to add any diagnostic or procedural comments with specific locations on body map.
Patient Database & Storage
Automated Reporting
Advanced and Customisable Multi-Featured Software
MoleMax Systems
Our Story
With more than 20 years of experience in dermoscopy, MoleMax Systems (as a division of Macquarie Medical Systems) focuses on delivering safe, high quality and efficient tools which help medical practices implement strategies for the best patient-centred care.
Our vision is to revolutionise and redefine the traditional MoleMax digital skin imaging system by making it a more economical and effective tool for quick and reliable early detection of skin cancer.